Alpha Tau is a private Israeli life sciences company focusing on the development and commercialization of a groundbreaking radiation therapy for the treatment and eradication of solid tumors.

Alpha Tau is the developer of a breakthrough alpha radiation cancer therapy intended to treat solid cancer tumors. The company’s therapy utilizes alpha radiation that treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha-emitting atoms into the tumor, enabling physicians to treat small tumors and metastatic lesions that has several significant clinical advantages.

INDUSTRY

MILESTONES

Arc investment: 2018

FOUNDERS

Uzi Sofer

ARC TEAM

Akbar Dawood

LATEST NEWS

Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Radiotherapy for Solid Tumors

PR NewsWire26-Nov-2019

Tagged Entity: